AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development
Clinical Development of Mipomersen, an Antisense Second-Generation Oligonucleotide Targeting Apolipoprotein B
Tejdip Singh, M.D., Medical Director, Global Patient Safety and Risk Management, Genzyme Corporation, USA
Oligonucleotide and Delivery Platform Optimization Strategies for siRNA Drug Development
Laura Sepp-Lorenzino, Ph.D., Senior Director, RNA Therapeutics, Merck & Co., Inc., USA
Recent Advances in Routes of Delivery for Peptide Pharmaceuticals
Nozer Mehta, Ph.D., Vice President, R&D, UniGene Laboratories, Inc., USA
Overview of Peptide Therapeutics and Vaccines in Development
Yuji Heike, M.D., Ph.D., Chief of Medical Staff, Department of Medical Oncology, National Cancer Center Hospital, Japan
Evolution and Development of GLP-1 Based Therapeutics
Andrew A. Young, M.D., Ph.D., Vice President, Head, Enterendocrine Biology, GlaxoSmithKline, USA
A Pivotal Year for Oligonucleotide Therapeutics
Arthur A. Levin, Ph.D., Chief Development Officer, Santaris A/S, USA and Denmark
RaPID Selection of a New Class of Peptide Drug Leads against Various Therapeutic Targets
Hiroaki Suga, Ph.D., Professor, Chemical Biology and Biotechnology Lab, The University of Tokyo, Japan
超過200名的科學家和商務人員參加2011年3月2∼4日在東京舉行的AsiaTIDES 2011，希望能進行交流。AsiaTIDES是能學習以寡核酸及胜肽（ Peptide）作為基礎之治療藥的最新研究動向及有關製造技術的活動。世界各國的引薦者在此研習會中報告最新動向。在東京舉行、非常方便的論壇，AsiaTIDES具有日本其他活動沒有的計畫內容。
會議聚焦於傳遞技術、微RNA、RNAi、胜肽（ Peptide）及寡糖（oligo）的製造•分析之最新動向，包含Oligo Safety Working Group和AsiaTIDES之前舉行的JPMA會議報告，傳達有關法規的報告。參加者能詳細學習到有關生物分析技術的詳細技巧和登記治療效驗藥的寡糖（oligo）和胜肽（ Peptide）藥劑的開發方法。
深受好評的重點演講：
Design of Lipid Nanoparticle Systems for the Systemic Delivery of siRNA
Pieter Cullis, Ph.D., FRSC
Professor, Biochemistry; Director, Nanomedicine Research Group
University of British Columbia, Canada
Supramolecular Structures from Block Copolymers for Nanocarriers in Oligonucleotide Delivery
Kazunori Kataoka, Ph.D.
Professor, Materials Engineering and Center for Disease Biology and Integrated Medicine
University of Tokyo, Japan
Transdermal Patch Delivery of Peptide Drugs
Eric Tomlinson, Ph.D., D.Sc.
President and Chief Executive Officer
Altea Therapeutics Corporation, USA
Clinical Breakthroughs in Transdermal Delivery of Peptides
Daphna Heffetz, Ph.D.
CEO and Director
TransPharma Medical Ltd, Israel
Stapled α-Helical Peptides: The Twists and Turns of Drug Discovery
Tomi K. Sawyer, Ph.D.
Senior Vice President and Chief Scientific Officer
Aileron Therapeutics Inc., USA
AsiaTIDES will be held again in March 2012 in Tokyo. Plan now to meet the leading players and access the latest data at AsiaTIDES.
中文官方網站營運：IBC Life Sciences 代理商 日商環球訊息有限公司